TMT 10-plex, 11-plex, and 18-plex Technologies: Principles and Application Scenarios
As proteomics research advances into the era of high-throughput analysis and large-scale cohorts, TMT (Tandem Mass Tag)-based multiplexed quantitative proteomics has become widely adopted. This approach enables the simultaneous analysis of multiple samples within a single LC-MS/MS run, thereby significantly reducing batch effects and overall experimental time. It is extensively applied in disease biomarker discovery, drug target validation, and multi-omics integration studies. Currently, mainstream TMT product formats include 10-plex, 11-plex, and 18-plex, each designed to accommodate different sample sizes and research demands. This article systematically describes the principles, distinctions, and typical application scenarios of these TMT technologies, and provides guidance on selecting appropriate strategies based on specific project requirements.
Core Principles of TMT Multiplexed Quantification
1. Structure of TMT Labels
TMT labels consist of three functional components:
(1) Reporter ion: releases signature ions during MS/MS fragmentation, enabling sample-specific quantification.
(2) Mass balance group: ensures identical precursor masses across different tags during MS1 scanning.
(3) Reactive group: covalently binds to the N-terminus or lysine residues of peptides, thereby enabling stable labeling.
2. Quantification Workflow
(1) Different samples are labeled with distinct TMT tags.
(2) Labeled samples are combined in equal amounts and subjected to LC-MS/MS analysis.
(3) Relative quantification across samples is achieved at the MS/MS level based on reporter ion intensities.
Technical Characteristics of TMT 10-plex, 11-plex, and 18-plex
1. TMT 10-plex
(1) Enables simultaneous analysis of up to 10 samples, making it suitable for small- to medium-scale studies (e.g., routine biological replicates and fundamental research).
(2) Requires relatively high mass resolution for reporter ion detection (typically compatible with Orbitrap systems).
(3) Offers lower cost and is widely used in academic research.
2. TMT 11-plex
(1) Introduces an additional channel based on the 10-plex format, typically used as a reference (bridge) sample to facilitate cross-batch normalization.
(2) Commonly applied in large cohort studies involving multiple analytical batches.
(3) Enhances data consistency and improves comparability across batches.
3. TMT 18-plex
(1) Represents the latest generation of TMT technology, enabling the simultaneous analysis of up to 18 samples in a single experiment, thereby substantially increasing throughput.
(2) Requires higher mass spectrometric resolution and MS/MS accuracy, typically supported by advanced platforms such as Orbitrap or timsTOF Pro.
(3) Particularly well suited for large-scale clinical cohorts, drug screening, and multi-omics integration, effectively reducing batch effects while lowering per-sample costs.
Selection Strategies for TMT Technologies
1. Sample Size
(1) ≤10 samples: TMT 10-plex is sufficient.
(2) 10-20 samples: TMT 11-plex is recommended, with the inclusion of a reference sample for batch normalization.
(3) ≥18 samples or studies requiring single-run coverage of large cohorts: TMT 18-plex is preferred to minimize batch variability.
2. Research Type
(1) Basic research (e.g., signaling pathways and PTM studies): 10-plex or 11-plex is generally adequate.
(2) Clinical cohort studies or drug research: 18-plex provides clear advantages by accommodating larger sample sets.
(3) Multi-omics integration: 18-plex is more suitable for joint analysis with transcriptomics and metabolomics.
3. Budget and Instrumentation
(1) TMT 10-plex offers the lowest cost and is suitable for projects with limited funding.
(2) TMT 18-plex requires high-end mass spectrometry platforms (e.g., Orbitrap Exploris 480), but provides a lower cost per sample due to increased multiplexing capacity.
Typical Application Scenarios of TMT Technology
1. Disease Biomarker Discovery
Comparative proteomic profiling between disease and control groups enables the identification of candidate biomarkers, thereby accelerating early diagnostic research.
2. Drug Target Validation and Mechanistic Studies
Monitoring dynamic protein changes before and after drug treatment facilitates the construction of protein regulatory networks associated with drug response.
3. Multi-omics Integration
Integration with transcriptomics and metabolomics supports the development of disease regulatory models and enables system-level insights into biological mechanisms.
4. Clinical Translational Research
TMT 18-plex enables the analysis of large-scale clinical cohorts within fewer batches, significantly reducing batch effects and supporting multi-center collaborative studies.
In summary, TMT 10-plex, 11-plex, and 18-plex technologies each offer distinct advantages and are suited to proteomics studies of varying scales and objectives. Selecting an appropriate strategy, together with robust experimental platforms and professional data analysis support, is critical for ensuring successful project execution. For multiplexed TMT-based proteomics studies, MtoZ Biolabs provides customized technical solutions and consultation services.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
